Jia (Jenny) Liu MD PhD
@JiaJennyLiu
Followers
1K
Following
4K
Media
340
Statuses
1K
Early Phase Trials Medical Oncologist Translational Researcher @kinghorncancer SVH Sydney; Associate Professor @UNSW; #PrecisionMedicine #drugdevelopment
Sydney, New South Wales
Joined August 2017
Jia Jenny Liu Have Been Promoted to Conjoint Associate Professor at UNSW Medicine & Health @JiaJennyLiu @UNSWMedicine
https://t.co/q3x51QfREa
#Cancer #Oncology #OncoDaily #Health #Medicine @CancerWorldmag
0
1
8
2011 PhD student → 2025 drug development oncologist. A long road, a lot of growth, and so many people to thank along the way. Grateful to be promoted to Conjoint Associate Professor at @UNSW. Excited for the next stage of global collaboration in early phase trials 🧬🧫🔬👩🏻⚕️
0
1
18
20 Years of Cancer Research at Cancer Institute NSW Awards - Jia (Jenny) Liu (@JiaJennyLiu) @cancerNSW
https://t.co/nAqHQ8ztsc
#OncoDaily #Oncology #Cancer #Health #Medicine #MedX #CancerResearch
0
1
6
Wonderful to see, @Nickymitchell, looking forward to seeing the fruits of your efforts in in March and September! @oncodocsydney @ChrisKarapetis @JiaJennyLiu @pankajpanda86 @yysoon01 #acordism
Very inspiring AoNZ concept development workshop today! Bring on #ACORD26 @MartinStockler
0
2
2
Another outstanding @WIN_Consortium international MTB that featured a case of adenosquamous pancreatic cancer with liver and retroperitoneal metastases, KRASG12D, CDKN2A/2B and MTAP copy number loss, p53, SMAD4, and KMT2C mutations, XPO1 and Myc amplification and a case of high
3
2
10
Patient-Led Study on Human-Centred Clinical Trials - @JiaJennyLiu
https://t.co/qXEeV7QRtf
#Cancer #OncoDaily #Oncology #MedEd #MedTwitter #MedX #MedOnc @CancerWorldmag
0
1
4
Just published a paper co-authored with early-phase trial patients. It took far longer than it should have… a sign of how undervalued patient experience still is in oncology. Cancer drug development must be human-centred, not just molecule-centred. 🔗: https://t.co/gp94RUBGsB
1
6
15
Important new data from @EliLillyandCo presented at @AACR @theNCI @EORTC 2025 👉 independent validation of heterogeneous membranous NECTIN-4 expression in UC! NECTIN-4 was only detected in 113/176 EV-naïve UC specimens (primary + metastatic), app. 1/3 is NECTIN-4 negative.
5
24
52
@YouTube @Spotify @ApplePodcasts 🌏 We congratulate the @myESMO Mentorship Programme, the @ASCO IDEA program, the NOMP @JiaJennyLiu and all the initiatives that are making #mentorship, in #oncology, a priority across the globe.
0
1
1
Congrats @RashaCosman on late breaking oral presentation, showcasing safety and MOA of novel in vivo CAR targeting TROP2 expressing tumors #SITC25 @NECTANSW - led trial from 🇦🇺 👏. This technology will expand access to solid tumor cell therapy 🌟
0
1
11
After targeted therapy, some MSS CRC tumors show elevated TMB, yet fail to elicit immune response. This highlights the gap between genomic changes and true immunogenicity. We need better biomarkers than TMB alone to guide IO strategies in this setting @OncoAlert @OncoReporte
0
17
59
50 Years of Cellular Therapy at St Vincent’s Health Network - @JiaJennyLiu
https://t.co/1Jkg7Rnvlk
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #CellularTherapy #StVincent
0
1
3
Why fundamental research is fundamental to progress, seeding major breakthroughs Editorial @Nature this week And 7 basic science discoveries that changed the world https://t.co/0YrKabc7ff
https://t.co/SM11QSJhWz
6
205
559
A week since a fantastic ESMO2025 @MyriamChalabi @DrChoueiri #ESMOAmbassadors🙏🙏 though Messe a ‘Marmite’ venue! Personal stand out moments? An assured NICHE pMMR presentation #DrYaraVershoor 🎤drop @Nature, @GillSharlene CRC discussant + @CharlesSwanton Powerhouse Keynote 👏👏
3
1
14
Special thanks to our inspiring guests and colleagues from the first series @marklewismd @JiaJennyLiu @Onco_Cifu88 @TeresaSAmaral @FAndreMD @DrJonLim Dr Nicky Thorp and also thanks to our guests of the next series Dr Paola Julve, Dr Yago Garitaonaindía, Dr. Imène Hadji @ErulEnes.
1
2
4
Totally agree @curijoey - taking a post-#ESMO25 recovery pause in your beautiful home country 🇮🇹 🍷🫒⛪️ at the moment… before return to #drugdevelopment rat race! 🇦🇺
Sometimes you just need to pause. Not because you’re lost, but because even the brightest path becomes clearer when you take a moment to breathe and reflect. 🌿
1
1
8
🌏 Full circle moment — from developing my first trial protocol as a trainee at @ACORDISM to now being elected Deputy Convenor (2026) and incoming Chair of the 🇦🇺/APAC Oncology Research Workshop. 🙏 opportunity to train the next gen of clinical trialists https://t.co/Xs18tBOnUA
1
0
23
Janice Tsang: It’s time for an adaptive and integrative approach, a mindset shift from #WorkLifeBalance to #WorkLifeIntegration. #ESMO25 #ESMO4Carers
2
2
7
📣 All #ESMO25 congress sessions with speaker permission are now online for registered delegates & ESMO members on #OncologyPRO Watch on demand and stay at the forefront of oncology. 🔗 https://t.co/Xb4tjHltTC
2
23
70
Every young oncologist interested in improving oral presentation skills should watch @tompowles1 masterful presidential delivery of IMvigor011. The slides alone do not to his art of communication enough justice... You will need #ESMO25 access for this one.
1
30
176